Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We will evaluate the effect of food on the bioavailability of the components of PN400
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | Other | PN400 administered after meal |
|
| 2 | Other | PN400 administered prior to meal |
|
| 3 | Other | PN400 administered prior to meal |
|
| 4 | Other | PN400 followed by fast |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| PN400 | Drug | naproxen/esomeprazole |
|
| Measure | Description | Time Frame |
|---|---|---|
| To determine the effects of food eaten at different times on the bioavailability of the components of PN400 following a single oral dose in healthy subjects. | 72-hours |
| Measure | Description | Time Frame |
|---|---|---|
| To assess the safety and tolerability of PN 400 under fasting and fed conditions. | entire study duration |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Austin | Texas | United States |
Not provided
| ID | Term |
|---|---|
| D001168 | Arthritis |
| ID | Term |
|---|---|
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided